Peripherally inserted central catheters lead to a high risk of venous thromboembolism in children.


Journal

Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509

Informations de publication

Date de publication:
16 01 2020
Historique:
received: 01 07 2019
accepted: 28 10 2019
pubmed: 8 1 2020
medline: 21 4 2020
entrez: 8 1 2020
Statut: ppublish

Résumé

Venous thromboembolism (VTE) incidence in children has sharply increased with the majority of cases secondary to central venous catheters (CVCs). Among CVCs, the number of peripherally inserted central catheters (PICCs) placed has risen significantly. In this multicenter, prospective, observational cohort study, we enrolled patients aged 6 months to 18 years with newly placed PICCs or tunneled lines (TLs). We evaluated the incidence of VTE, central line-associated bloodstream infections (CLABSIs), and catheter malfunctions in PICCs and TLs, and risk factors of CVC-related VTE. A total of 1967 CVCs were included in the analysis. The incidence of CVC-related VTE was 5.9% ± 0.63%. The majority of the cases, 80%, were in subjects with PICCs, which had a significantly higher risk of catheter-related VTE than subjects with TLs (hazard ratio [HR] = 8.5; 95% confidence interval [CI], 3.1-23; P < .001). PICCs were significantly more likely to have a CLABSI (HR = 1.6; 95% CI, 1.2-2.2; P = .002) and CVC malfunction (HR = 2.0; 95% CI, 1.6-2.4; P < .001). Increased risk of CVC-related VTE was found in patients with a prior history of VTE (HR = 23; 95% CI, 4-127; P < .001), multilumen CVC (HR = 3.9; 95% CI, 1.8-8.9; P = .003), and leukemia (HR = 3.5; 95% CI, 1.3-9.0; P = .031). Children with PICCs had a significantly higher incidence of catheter-related VTE, CLABSI, and CVC malfunction over TLs. The results suggest that pause be taken prior to placing CVCs, especially PICCs, due to the serious complications they have been shown to cause.

Identifiants

pubmed: 31909784
pii: S0006-4971(20)62303-5
doi: 10.1182/blood.2019002260
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

220-226

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 by The American Society of Hematology.

Auteurs

Julie Jaffray (J)

Children's Hospital Los Angeles, Los Angeles, CA.

Char Witmer (C)

Children's Hospital of Philadelphia, Philadelphia, PA.

Sarah H O'Brien (SH)

Nationwide Children's Hospital, Columbus, OH.

Rosa Diaz (R)

Texas Children's Hospital, Houston, TX; and.

Lingyun Ji (L)

Department of Preventative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA.

Emily Krava (E)

Children's Hospital Los Angeles, Los Angeles, CA.

Guy Young (G)

Children's Hospital Los Angeles, Los Angeles, CA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH